Going green Next Generation Pharmaceutical (Europe)              Collaboration and innovation Next Generation Pharmaceutical (Europe)              Pushing the frontiers of disease prevention Next Generation Pharmaceutical (Europe)              The power of perception Next Generation Pharmaceutical (Europe)              Supply chain optimisation Next Generation Pharmaceutical (Europe)              Translational medicine paradigm: hip or hype? Next Generation Pharmaceutical (US)              The evolution of drug safety Next Generation Pharmaceutical (US)              Investigating cell death resistance in tumor cells Next Generation Pharmaceutical (US)              A culture of engagement and inclusion Next Generation Pharmaceutical (US)              Leading Lilly forward Next Generation Pharmaceutical (US)             
Contributors

Wayne Pisano
Wayne Pisano
CEO, sanofi pasteur
Pushing the frontiers of disease prevention

Jean Stéphenne
Jean Stéphenne
President, GlaxoSmithKline Biologicals
Vaccines for the world

Jan Lundberg
Jan Lundberg
EVP Discovery Research, AstraZeneca
A personalised approach

Paola Ricci
Paola Ricci
SEVP Pharmaceutical Affairs, Merck Serono
Collaboration and innovation

Ralph Haefeli
Ralph Haefeli
Head of Global TechOps IT, Novartis
Crossing organisational boundaries

Industry Analysts

Outsourcing advantages
Outsourcing offers multiple benefits for pharmaceutical companies. NGP asked Marcel Velterop of Dr Reddy’s how it can help reduce costs, achieve higher levels of performance, free up resources for higher value activities and gain access to capabilities and resources that are not available internally.
More >>

Clean zone design
With the emergence of new technologies and production methods for biotechnology, nanotechnology, cytotoxic/potent compounds and personalised medicines, manufacturing cleanroom environments are changing. NGP asked Hach Ultra’s Joe Gecsey about current and future trends in cleanroom technologies.
More >>

Previous Analysts

Healthcare systems for the 21st century
Since May 2007, Arthur J. Higgins, Chairman of the Board of Management, Bayer HealthCare AG, has been the new President of the General Assembly of the European Federation of Pharmaceutical Industries and Associations (EFPIA).
More >>

Getting marketing back on track
Dr Barrie James explains why and how the pharma industry need to get a grip on their marketing before the phenomena of big pharma goes the way of the dodo.
More >>

A suitable alternative
As you will have read in many of the articles in this issue, the pharmaceutical industry is experiencing a slowdown.
More >>

Mind the gap?
The pharmaceutical industry has developed something of a poor reputation due to pricing issues and drug safety problems.
More >>

Meeting new FDA regulations: supplying the full package
Product safety drives the pharmaceutical industry ? and Sigpack Systems? pharmaceutical clients must abide by and, in many cases, be one step ahead of FDA mandates.
More >>

Thermodynamics and heat exchanges in refrigerated packaging
The so-called ?cold chain? allows manufacturers and distributors to keep the temperature of a product as close as possible to its storage temperature, through its transportation to the final destination.
More >>

The Publication COVER: Next Generation Pharmaceutical Europe 5

See More >>

European Commission
Vendor Perspectives

Article
Customer Value Integration
Capgemini
More >>

Article
The Preclinical Games – faster, higher, stronger
Pharmatest Services Ltd.
More >>

Article
A cure for the pharma R&D blues
DO-Coop Technologies
More >>

Article
Intelligent, integrated and hygienic
Bürkert Gmbh
More >>

Article
Leading pharmaceutical company uses CRM and BI to drive business results
Add IT Solutions
More >>

Article
Securing growth and innovation – how the Pharmaceutical industry can benefit from information technology
Microsoft
More >>

The Leader